- Press Release -

Rockville, Md. The global scoring balloon catheter market is set for steady growth through 2022, according to Fact.MR, as rising coronary artery and peripheral vascular disease pushes clinicians toward devices that handle cases conventional catheters cannot. Scoring technology helps with fibrocalcific lesions resistant to dilation and reduces problems such as uncontrolled dissection and insufficient luminal expansion.

Coronary artery procedures dominate use, nylon leads by material, and hospitals account for most revenue. Cardiac catheterization laboratories are the fastest-growing setting.

Indications, Materials and Settings

Coronary artery disease is the leading indication, worth around US$ 40 Mn in 2017, with peripheral vascular disease next. By raw material, nylon leads at about US$ 30 Mn in 2017, with North America the major market, while polyurethane posts the higher growth rate. Among end users, hospitals lead by revenue, with Europe a major contributor, and cardiac catheterization laboratories grow fastest.

Clinical Need Drives Demand

The market runs on the limits of older devices. Because conventional balloon catheters struggle with resistant lesions, clinicians increasingly favour scoring designs for both coronary and peripheral vascular work, and manufacturers are adopting scoring technology accordingly. Set against that, risks of artery collapse and infection during catheterization keep growth in check.

Suppliers and Their Playbook

The field brings together cardiovascular device specialists and large medical technology firms.

• B. Braun Melsungen AG, Medtronic Plc, Tokai Medical Products Inc., BIOTRONIK SE & Co. KG, Terumo Corporation, Boston Scientific Corporation, Jotech GmbH, MicroPort Scientific Corporation, Hexacath, Meril Life Sciences Pvt Ltd, Cordis Corporation, Abbott Laboratories, Cardionovum GmbH, and Cook Medical INC are among the key players in the report.

Reading the Market for Decisions

For device makers, growth favours scoring designs for complex lesions across coronary and peripheral use. Investors get a small, specialised market with steady, clinical-led demand. Procurement and hospital teams can plan around coronary applications carrying volume, nylon leading material, and hospitals leading demand through 2022.

About the Report

Fact.MR's study covers the global scoring balloon catheter market for the 2017 to 2022 forecast period, with segmentation by raw material, indication, end user and region. It sizes each segment, maps the competitive field, and weighs the clinical forces shaping demand. Further detail is available in the scoring balloon catheter market report.

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. The firm is known for its syndicated research, custom research and consulting solutions, helping clients make decisions on demand, competition, investment, procurement and future growth.